Difficulty: Medium
Average Score: 64%
Practice
An infant with marked cyanotic heart defect with decreased pulmonary vascularity should be treated with:
Correct answer
B
Rationale
In this scenario, the correct answer is B) Prostaglandin E1. Infants with marked cyanotic heart defects and decreased pulmonary vascularity often have conditions like ductal-dependent congenital heart diseases (CHD) where a patent ductus arteriosus (PDA) is necessary to maintain systemic blood flow. Prostaglandin E1 helps keep the ductus arteriosus open, allowing for adequate systemic blood flow in these infants.
Option A) Epinephrine is used in situations of cardiac arrest or severe hypotension, not specifically for treating cyanotic heart defects. Option C) Dopamine is a medication used to improve cardiac output and blood pressure, but it is not the primary treatment for cyanotic heart defects. Option D) Digoxin is a cardiac glycoside used to treat heart failure and certain arrhythmias, but it is not the appropriate treatment for cyanotic heart defects with decreased pulmonary vascularity.
Educationally, understanding the importance of prostaglandin E1 in managing ductal-dependent CHD in infants is crucial for pediatric nursing practice. This knowledge ensures timely and appropriate interventions to support these vulnerable patients, highlighting the significance of accurate medication administration in pediatric cardiac care.
Option A) Epinephrine is used in situations of cardiac arrest or severe hypotension, not specifically for treating cyanotic heart defects. Option C) Dopamine is a medication used to improve cardiac output and blood pressure, but it is not the primary treatment for cyanotic heart defects. Option D) Digoxin is a cardiac glycoside used to treat heart failure and certain arrhythmias, but it is not the appropriate treatment for cyanotic heart defects with decreased pulmonary vascularity.
Educationally, understanding the importance of prostaglandin E1 in managing ductal-dependent CHD in infants is crucial for pediatric nursing practice. This knowledge ensures timely and appropriate interventions to support these vulnerable patients, highlighting the significance of accurate medication administration in pediatric cardiac care.